Culture eats strategy for breakfast
Culture drives our success. It’s all about people and partnerships. Transparency, empathy and dedication is what guides both, our thinking and acting. Together with an experienced team we are committed to the therapeutic potential of medical cannabis.
Dascoli Pharma AG is a Swiss-based company, specialized in the supply and distribution of medical cannabis, as well as in the training of healthcare professionals in this field. With an experienced team, we are a reliable partner when it comes to providing services and advice towards the therapeutic potential of medical cannabis.
MEET THE TEAM
The greatest asset
of a company
Andrew Petronanos
CEO & Founder
For many years, Andrew has been working on the question of how to make medical cannabis more accessible for those in need. As founder and CEO of Dascoli Pharma he connects the dots and sets the strategic direction. With his team-building and networking skills he is setting the course for growth. Before founding Dascoli Pharma, he led a consulting agency forentrepreneurs and investors in the hemp, CBD and cannabis industry.
With extensive experience in business operations and entrepreneurship, Andrew has successfully led teams in highly regulated markets. Before founding Dascoli Pharma, he led a consulting agency for entrepreneurs and investors in the hemp, CBD, and cannabis industry. Andrew is
committed to driving the company’s growth while ensuring compliance and operational excellence.
Sandra Müller
Head Pharmacist
For many years, Andrew has been working on the question of how to make medical cannabis more accessible for those in need. As founder and CEO of Dascoli Pharma he connects the dots and sets the strategic direction. With his team-building and networking skills he is setting the course for growth. Before founding Dascoli Pharma, he led a consulting agency forentrepreneurs and investors in the hemp, CBD and cannabis industry.
Sandra leads the pharmacy team, focusing on patient care and operational compliance. She ensures that all processes meet Swiss pharmaceutical standards, delivering exceptional service to both prescribers and patients. Sandra holds a MAS in Nutrition & Health and a Pharmacist degree from ETH Zurich.
Bruno Keller
FvP / QP
For many years, Andrew has been working on the question of how to make medical cannabis more accessible for those in need. As founder and CEO of Dascoli Pharma he connects the dots and sets the strategic direction. With his team-building and networking skills he is setting the course for growth. Before founding Dascoli Pharma, he led a consulting agency forentrepreneurs and investors in the hemp, CBD and cannabis industry.
Bruno oversees product quality and safety, ensuring that all distribution operations meet Good Distribution Practice (GDP) standards. As the owner and General Manager of Pharmatrend GmbH, he brings long-term experience in the pharmaceutical industry and quality management, acting as an independent service provider and consultant since 2010.
Sarah Petronanos
Head of Brand
For many years, Andrew has been working on the question of how to make medical cannabis more accessible for those in need. As founder and CEO of Dascoli Pharma he connects the dots and sets the strategic direction. With his team-building and networking skills he is setting the course for growth. Before founding Dascoli Pharma, he led a consulting agency forentrepreneurs and investors in the hemp, CBD and cannabis industry.
As an external agency, Sarah is an integral part of the team. She is responsible for branding, the company's brand strategy and the realization of training materials & events. With the foundation of her own agency Stadthelden, she has been working in the fields of communication, events, branding & design for more than 10 years and has worked with national & international clients. In addition to her university degree in Business Communication, she has specialized in the field of healthcare marketing.
Dr. Simon Nicolussi
Chief Scientific Officer
Medical Affairs
For many years, Andrew has been working on the question of how to make medical cannabis more accessible for those in need. As founder and CEO of Dascoli Pharma he connects the dots and sets the strategic direction. With his team-building and networking skills he is setting the course for growth. Before founding Dascoli Pharma, he led a consulting agency forentrepreneurs and investors in the hemp, CBD and cannabis industry.
A renowned expert in cannabinoid therapies, Simon holds a PhD in Biochemistry and Molecular Biology. With over a decade of experience in research, medical affairs, and regulatory compliance, he shapes industry standards and education initiatives as aboard member of the Swiss Society of Cannabis in Medicine (SGCM).
Dr. Stefan Wolf
Betm vP
For many years, Andrew has been working on the question of how to make medical cannabis more accessible for those in need. As founder and CEO of Dascoli Pharma he connects the dots and sets the strategic direction. With his team-building and networking skills he is setting the course for growth. Before founding Dascoli Pharma, he led a consulting agency forentrepreneurs and investors in the hemp, CBD and cannabis industry.
Stefan is an expert in narcotics compliance and regulatory matters, ensuring that Dascoli’s operations adhere strictly to Swiss narcotics laws. In addition to his pharmaceutical expertise, he is the founder and owner of Dr. Brauwolf, the first show craft brewery in Zurich Binz.
Natalie Chaimowicz
Chief Commercial Officer
For many years, Andrew has been working on the question of how to make medical cannabis more accessible for those in need. As founder and CEO of Dascoli Pharma he connects the dots and sets the strategic direction. With his team-building and networking skills he is setting the course for growth. Before founding Dascoli Pharma, he led a consulting agency forentrepreneurs and investors in the hemp, CBD and cannabis industry.
Natalie brings a wealth of expertise in commercial strategy, business development, and customer relationship management. She leads Dascoli’s commercial initiatives, fostering strong partnerships with prescribers, distributors, and healthcare providers, while driving revenue growth across key markets.
THE COMEBACK
Cannabis as a medicine
Interest in medical cannabis has grown strongly due to the potentially broad range of uses. For this reason, the Swiss parliament has lifted the ban on cannabis for medicinal purposes in the Narcotics Act as of August 2022.
In the absence of guidance on products, patients often seek out information on their own to investigate which products and dosing may help with their particular symptoms. This process is not optimal, and usually involves patients experimenting before finding a regimen that works for them.
By building a network of sustainable partnerships, we foster the treatments of medical cannabis.
WHAT WE STAND FOR
Committed to the therapeutic potential of medical cannabis
"Our vision is to do everything that ensures patients have safe access to medical cannabis and can rely on expert medical care in this field.
We put our heart and soul into constantly pioneering new paths."
Andrew Petronanos | CEO & Founder
OUR ADVISORS
Supported
by great minds
